Dr. Rahul P. Sharma (Interventional Cardiologist, Stanford Medical Center) introduces the latest FFRangio software, reviews important clinical evidence, and shows a case example highlighting the benefits of non-invasive, multi-vessel FFR. Presented at CVIT Japan February 2021.
The CathWorks FFRangio System delivers the patient benefits of FFR on a wire-free and drug-free platform, complete with accurate multi-vessel physiology and advanced insights to quickly optimize and confirm PCI decisions for more patients.
